Who owns VERTEX PHARMACEUTICALS INC / MA?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of VRTX from SEC Form 13F filings across 1,756 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 1,756 institutions disclosed 241.4M shares of VERTEX PHARMACEUTICALS INC / MA worth $119.71B — about 95.2% of shares outstanding; the largest disclosed holder is Capital World Investors. Source: SEC Form 13F filings, parsed by EvidInvest.
1,756
13F holders
$119.71B
value, 2026 filers
95.2%
of shares outstanding (241.4M sh)
228
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of VRTX's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Capital World Investors | 26.1M | $12.97B | 1.5% | 10.3% | +2.9% |
| 2 | BlackRock, Inc. | 24.1M | $11.98B | 0.2% | 9.5% | +0.6% |
| 3 | Capital Research Global Investors | 19.5M | $9.68B | 1.4% | 7.7% | -7.7% |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 16.6M | $8.24B | 0.2% | 6.5% | +0.4% |
| 5 | STATE STREET CORP | 11.9M | $5.90B | 0.2% | 4.7% | +1.2% |
| 6 | Invesco Ltd. | 8.0M | $4.00B | 0.3% | 3.2% | +214.1% |
| 7 | JPMORGAN CHASE & CO | 6.5M | $3.26B | 0.2% | 2.6% | -7.3% |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | 6.0M | $2.98B | 0.2% | 2.4% | -2.0% |
| 9 | VANGUARD PORTFOLIO MANAGEMENT LLC | 4.9M | $2.42B | 0.1% | 1.9% | -5.2% |
| 10 | Capital International Investors | 4.7M | $2.33B | 0.5% | 1.9% | -8.4% |
| 11 | LOOMIS SAYLES & CO L P | 3.9M | $1.95B | 2.4% | 1.5% | -2.1% |
| 12 | FRANKLIN RESOURCES INC | 3.3M | $1.66B | 0.4% | 1.3% | +507.3% |
| 13 | WELLINGTON MANAGEMENT GROUP LLP | 3.2M | $1.61B | 0.3% | 1.3% | +1.1% |
| 14 | MORGAN STANLEY | 3.2M | $1.61B | 0.1% | 1.3% | +1.7% |
| 15 | UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 3.1M | $1.53B | 0.3% | 1.2% | +1.0% |
| 16 | BANK OF AMERICA CORP /DE/ | 3.0M | $1.51B | 0.1% | 1.2% | +5.6% |
| 17 | ALLIANCEBERNSTEIN L.P. | 3.0M | $1.35B | 0.4% | 1.2% | -22.8% |
| 18 | JENNISON ASSOCIATES LLC | 3.0M | $1.49B | 0.9% | 1.2% | +9.4% |
| 19 | NORGES BANKNEW | 3.0M | $1.48B | 0.1% | 1.2% | new |
| 20 | AMERIPRISE FINANCIAL INC | 2.6M | $1.29B | 0.3% | 1% | -1.1% |
| 21 | NORTHERN TRUST CORP | 2.5M | $1.24B | 0.1% | 1% | -3.0% |
| 22 | GOLDMAN SACHS GROUP INC | 2.5M | $1.23B | 0.1% | 1% | +2.6% |
| 23 | Clearbridge Investments, LLC | 2.3M | $1.16B | 1.0% | 0.9% | -13.3% |
| 24 | VICTORY CAPITAL MANAGEMENT INC | 2.2M | $1.08B | 0.6% | 0.9% | +15.1% |
| 25 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 2.0M | $1.01B | 0.1% | 0.8% | +6.3% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.